Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety of batroxobin injection in acute cerebral infarction
ChiCTR2600117253Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of batroxobin in brain infarction, sponsored by Beijing Friendship Hospital. Primary endpoints: Blood routine, Blood biochemistry and 4 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
batroxobin
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2600117253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117253.